Li et al. employed LASSO, RF, and SVM-RFE algorithms to investigate genetic mechanisms of HF development after AMI, identifying IL1B, TIMP2, IFIT3, and P2RY2 as potential therapeutic targets (27). The gene discussed is IFIT3; the disease is hydrops fetalis.